Clinical Trial Update: The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Apatinib in heavily pretreated advanced non-squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Tongji University | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN